Pirocarbotrat(TM): A new radiopharmaceutical for the treatment of solid tumors - Comparative studies in N-nitrosomethylurea-induced rat mammary tumors

Nuclear Medicine and Biology

Volumn 24, Issue 6, 1997, Pages 559-564

  Zubillaga, M B ^a   Boccio, J R ^a   Nicolini, J O ^a   Ughetti, R ^a   Lanari, E ^b   Caro, R A ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Nuclear Medicine Department   (Argentina)

Author keywords

32P; Beta therapy; Brachytherapy; Rats; Treatment; Tumors

Indexed keywords

CHARCOAL; CHROMIUM PHOSPHATE P 32; GELATIN; METHYLNITROSOUREA; PHOSPHORUS 32; PIROCARBOTRAT; RADIOPHARMACEUTICAL AGENT; SODIUM DIHYDROGEN PHOSPHATE P 32; UNCLASSIFIED DRUG; PHOSPHORUS; PYROPHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRACHYTHERAPY; BREAST ADENOCARCINOMA; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG FORMULATION; FEMALE; NONHUMAN; RAT; SOLID TUMOR; TUMOR VOLUME; ANIMAL; BETA RADIATION; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; EXPERIMENTAL NEOPLASM; SPRAGUE DAWLEY RAT;

ANIMALS; BETA RAYS; BRACHYTHERAPY; CHARCOAL; DIPHOSPHATES; FEMALE; GELATIN; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYLNITROSOUREA; PHOSPHORUS RADIOISOTOPES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030608880     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(97)00070-X     Document Type: Article

References (34)

1. Agresti A. (1990) Categorical Data Analysis. John Wiley, New York.
2. 32P) for local irradiation of the central nervous system. Intern. J. Appl. Radiat. Isotopes 18, 97-100.
3. Anghileri L. J. (1968) Studies on colloidal chromic phosphate: an improved method of preparation and in situ precipitation by injection of papain. Intern. J. Appl. Radiat. Isotopes 19, 415-420.
4. Beardsley T. (1994) A war not won. Sci. Am. 270, 118-126.
5. Béclère, Cottenot and Laborde. (1922) Radiología y radiumterapia. In: Tratado de patología médica y de terapéutica aplicada. Editorial Publication, Barcelona.
6. Bergqvist L., Sundberg R., Rydén S. and Strand S. E. (1987) The "critical colloid dose" in studies of reticuloendothelial function. J. Nucl. Med. 28, 1424-1429.
7. Blasko J. C., Radge H. and Schumacher D. (1987) Transperineal percutaneous iodine-125 implantation for prostatic carcinoma using transrectal ultrasound and template guidance. Endocur. Hypertherm. Oncol. 3, 131-139.
8. Caro R. A. (1967) Contribución al estudio del oro coloidal radiactivo. PhD thesis. University of Buenos Aires, Argentina.
9. Cingolani H. and Houssay A. (1989) Fisiología Humana, Vol. 3, 6th edn. El Ateneo, Argentina.
10. Crusinberry R. A., Kramolowsky E. V. and Loening S. A. (1987) Percutaneous transperineal placement of gold 198 seeds for treatment of carcinoma of the prostate. Prostate 11, 59-67.
11. Czapski G. (1971) Radiation chemistry of oxygenated aqueous solutions. Ann. Rev. Phys. Chem. 22, 171-208.
12. 90Y microspheres. Nucl. Med. Biol. 14, 233-242.
13. Evans R. D. (1955) The Atomic Nucleus. McGraw-Hill Book Company, New York.
14. 32P]chromic phosphate colloid in cystic brain tumors. Stereotact. Funct. Neurosurg. 59, 166-168.
15. Gullino P. M., Pettigrew H. M. and Grantham F. H. (1975) N-nitrosomethylurea as mammary gland carcinogen in rats. J. Natl. Cancer Inst. 54, 401-404.
16. Harbert J. C. (1987) Nuclear Medicine Therapy. Thieme Medical Publishers, Inc. New York.
17. 153Sm]EDTMP: a potential therapy for bone cancer pain. Semin. Nucl. Med. 22, 41-45.
18. Jain R. K. (1994) Barriers to drug delivery in solid tumors. Sci. Am. 271, 42-49.
19. 186Re-HEDP as bone therapeutic radiopharmaceuticals. Nucl. Med. Biol. 14, 223-232.
20. Kirk D. (1995) Strontium-89 in the management of metastatic prostate cancer. Cancer Surv. 23, 211-215.
21. Lattimer, J. C., Corwin L. A., Stapleton J., Volkert W. A., Ehrhardt G. J., Ketring A. R., Hewett J. E., Simon J. and Goeckeler W. F. (1990) Clinical and clinicopathologic effects of samarium-153-EDTMP administered intravenously to normal beagle dogs. J. Nucl. Med. 31, 586-593.
22. Malmud L. S. (1992) Lines from the president: expanding the therapeutic applications of nuclear medicine. J. Nucl. Med. 33, 31N.
23. Maxon H. R. III, Thomas S. R., Hertzberg V. S., Schroder L. E., Englaro E. E., Samaratunga R., Scher H. I., Moulton J. S., Deutsch E. A., Deutsch K. F., Schneider H. J., Williams C. C. and Ehrhardt G. J. (1992) Rhenium-186 hydroxyethylidene diphosphonate for the treatment of painful osseous metastases. Semin. Nucl. Med. 22, 33-40.
24. Mitta A. and Robles A. M. (1986) Quality Control of Radiopharmaceuticals. ALABISMN, Montevideo, Uruguay.
25. 32P chromic phosphate for the treatment of hemophilic arthropathy. J. Bone Joint Surg. Am. 76, 482-488.
26. Rivera E. S., Andrade N., Martin G., Melito G., Cricco G., Mohamad N., Davio C., Caro R. and Bergoc R. M. (1994) Induction of mammary tumors in rat by intraperitoneal injection of NMU: histopathology and estral cycle influence. Cancer Lett. 86, 223-228.
27. Robinson R. G., Preston D. F., Spicer J. A. and Baxter K. G. (1992) Radionuclide therapy of intractable bone pain: emphasis on strontium-89. Semin. Nucl. Med. 22, 28-32.
28. Siegel H. J., Luck J. V., Siegel M. E., Quines C. and Anderson E. (1994) Hemarthrosis and synovitis associated with hemophilia: clinical use of P-32 chromic phosphate synoviorthesis for treatment. Radiology 190, 257-261.
29. Silbertstein E. B., Elgazzar A. H. and Kapilivsky A. (1992) Phosphorous-32 radiopharmaceuticals for the treatment of painful osseous metastases. Semin. Nucl. Med. 22, 17-27.
30. Sokal R. R. and Rohlf F. J. (1981) Biometry. Freeman and Company, San Francisco.
31. Spanos W. J. Jr., Day T. Jr., Jose B., Paris K. and Lindberg R. D. (1994) Use of P-32 in stage III epithelial carcinoma of the ovary. Gynecol. Oncol. 54, 35-39.
32. 32P]chromic phosphate for treatment of solid tumors. Act. Physiol. Pharmacol. Latinoam. 46, 103-110.
33. 32P]phosphate in treatment of solid tumors. Nucl. Med. Biol. 23, 907-910.
34. Zubillaga M. B., Boccio J. R., Nicolini J. O., Ughetti R., Lanari E. and Caro R. (1997) Braquiterapia de tumores sólidos: uso del fosfato crómico coloidal. Act. Physiol. Pharmacol. Latinoam., 47(3) (in press).